8-K
Current Report
Liminatus Pharma, Inc. Filed Acc 0001104659-26-080613
Material agreement · Acquisition or sale completed · Unregistered share sale · Bylaws or fiscal year change
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 3.02 Unregistered sales of equity securities
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading tm2619730d1_8k.htm…